About Evrima
Evrima is a Healthcare company based in Sydney (Australia) founded in 2018 by Charlotte Bradshaw. Active clinical trials and medical research are discovered and registered. It operates in the Healthcare and Business Services sectors. Evrima has raised $3 million across 1 funding round from investors including Wavemaker Partners, BridgeLane and Artesian. Its chief executive, as recorded, is Charlotte Bradshaw. Evrima offers products and services including Evrilink, Evripath, and Evriquest. Its focus areas include HR Services, Recruitment Services, HealthTech and Life Sciences Tech. Its legal entity is Evrima Technologies. Its competitors include Cloudstaff, HealthMatch and APM; 2 of its 3 listed competitors have raised funding.
Company details
Evrima was established in 2018 in Sydney, Australia, with Charlotte Bradshaw as founder and CEO. A platform is provided for identifying and enrolling in ongoing clinical trials and medical studies. The overall clinical trial process is streamlined as a result. Focus is placed on the healthcare technology sector, supporting research participants and trial coordinators across various medical fields.
- Headquarters Sydney, Australia
- Founders Charlotte Bradshaw
- SectorsHealthcareBusiness Services
- Email••••••••
- Website evrima.com
- Social LinkedIn Facebook Instagram
- Legal Name Evrima Technologies
- Total Equity Funding$3M (USD)
in 1 rounds
- Latest Funding Round$3M (USD), Seed
Sep 2022
- InvestorsWavemaker Partners
& 2 more
Products & Services of Evrima
Evrima offers a comprehensive portfolio of products and services, including Evrilink, Evripath, and Evriquest.
Platform for managing clinical trial data and processes efficiently.
Tool for GPs to search and refer patients to clinical trials.
Service for recruiting diverse participants in clinical trials.
Funding Insights of Evrima
Evrima has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Seed round of $3 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 1
- Last Round Seed — $3M
- First Round $3M
(Sep 2022)
- Investors Count 3
All 1 funding rounds of Evrima with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $3M | Seed | – | Artesian |
3 investors in total: 3 institutional.
Investors in Evrima
Evrima has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Wavemaker Partners, BridgeLane and Artesian.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
BridgeLane is operated as a single family office for investments. | bridgelane.com.au | Sydney, Australia | ||
Investments in early-stage technology companies are made by Wavemaker Partners. | 2003 | wavemaker.vc | Los Angeles, United States | |
Venture capital and private debt fund focused on climate, agrifood, health, AI, and multiple sectors | artesianinvest.com | Sydney, Australia |
Investor details for Evrima
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Evrima
1 people are tracked at Evrima (1 in leadership).
| Name | Role | Group |
|---|---|---|
Charlotte Bradshaw | Founder & CEO | Leadership |
Complete people profiles for Evrima
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Evrima
2 dated milestones of Evrima across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Evrima is founded.
- Funding First funding round of $3.0M.
Competitors of Evrima
Evrima has 3 listed competitors in our database, 2 of them funded. They include Cloudstaff, HealthMatch and APM.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cloudstaff.com | 2011 | Sydney, Australia | $22.61M | Outsourcing solutions are provided to businesses for operational efficiency. | ||
| healthmatch.io | 2016 | Surry Hills, Australia | $27.5M | Provider of patient recruitment platform | ||
| apm.net.au | 1994 | Perth, Australia | Outplacement, injury prevention, and assessment services are delivered to clients. |
Detailed competitors of Evrima
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Evrima
The website of Evrima (evrima.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 37.8% vs previous month
Websites whose visitors overlap most with Evrima. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
momentumclinicalresearch.com.au | momentumclinicalresearch.com.au | 100% | #1,089,398 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Evrima
Evrima was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Evrima is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Charlotte Bradshaw is the CEO of Evrima, as recorded in our data. They have also founded this company.
Evrima is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Seed of $3M, raised on Sep 2022.
Evrima was established in 2018 in Sydney, Australia, with Charlotte Bradshaw as founder and CEO. A platform is provided for identifying and enrolling in ongoing clinical trials and medical studies. The overall clinical trial process is streamlined as a result. Focus is placed on the healthcare technology sector, supporting research participants and trial coordinators across various medical fields.
Evrima's top competitors include Cloudstaff, APM and HealthMatch.
Evrima offers Evrilink, Evripath, and Evriquest.
Evrima has 3 investors. Key investors include Wavemaker Partners, BridgeLane, and Artesian.
Evrima operates through Evrima Technologies.